EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictors of Immediate Deterioration of the Child‐Pugh Classification From A to B After Transcatheter Arterial Chemo‐Embolization for Treatment‐Naive Hepatocellular Carcinoma

Kazuo Asano iD, Ken Kageyama, Akira Yamamoto, Atsushi Jogo iD, Mariko Nakano, Kazuki Murai iD, Yoshimi Yukawa-Muto, Naoshi Odagiri, Kohei Kotani, Ritsuzo Kozuka, Etsushi Kawamura, Hideki Fujii und 4 weitere

Cancer Medicine · 2024

DOI: 10.1002/cam4.70367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Kazuo Asano und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Osaka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic, Epirubicin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The purpose of this study was to evaluate the predictors of deterioration of the Child‐Pugh classification 1 month after transcatheter arterial chemo‐embolization (TACE) in patients with treatment‐naive hepatocellular carcinoma (HCC).

Methods

Between 2010 and 2020, consecutive patients who underwent conventional TACE using epirubicin as the initial treatment were enrolled. Patients with Barcelona Clinic Liver Cancer stage‐0, A or B and Child‐Pugh class A were included. The Child‐Pugh score was evaluated before treatment and 1 month after TACE. The following variables were analyzed by univariate and multivariate analyses as predictors of deterioration of the Child‐Pugh class from A to B: age, sex, etiology, serum albumin, bilirubin, prothrombin time (PT), encephalopathy, ascites, largest tumor diameter, tumor number, tumor location, α‐fetoprotein, protein induced by vitamin K absence or antagonist‐II, epirubicin dosage, ethiodized oil dosage, and number of treated liver segments.

Results

A total of 152 patients were retrospectively enrolled. The deterioration rate of the Child‐Pugh class from A to B was 8.6%. Multivariable analysis showed that serum albumin ≤ 3.8 g/dL, PT ≤ 80%, and largest tumor diameter ≥ 3.8 cm were predictors of deterioration of the Child‐Pugh class. The deterioration rate to Child‐Pugh class B was 0% in patients with up to one of these factors, 14.3% in those with two factors, and 70% in those with three factors.

Conclusions

A combination of serum albumin ≤ 3.8 g/dL, PT ≤ 80%, and largest tumor diameter ≥ 3.8 cm can predict the immediate deterioration of the Child‐Pugh classification from A to B following TACE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsChemoembolization, TherapeuticEpirubicinHumansMaleFemaleMiddle AgedAgedRetrospective StudiesAdultTreatment OutcomeAged, 80 and overSerum Albumin

Stichwörter der Autor:innen

Child‐Pugh classificationhepatocellular carcinomapreserved liver functiontranscatheter arterial chemoembolization

Substanzen

EpirubicinSerum Albumin

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
  • Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Department of Premier Preventive Medicine, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.

ORCID-Profile: Kazuo Asano, Atsushi Jogo, Kazuki Murai

Zitieren

APA

Asano, K., Kageyama, K., Yamamoto, A., Jogo, A., Nakano, M., Murai, K., Yukawa-Muto, Y., Odagiri, N., Kotani, K., Kozuka, R., Kawamura, E., Fujii, H., Uchida-Kobayashi, S., Enomoto, M., Kawada, N., & Miki, Y. (2024). Predictors of Immediate Deterioration of the Child‐Pugh Classification From A to B After Transcatheter Arterial Chemo‐Embolization for Treatment‐Naive Hepatocellular Carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.70367

Vancouver

Asano K, Kageyama K, Yamamoto A, Jogo A, Nakano M, Murai K, et al. Predictors of Immediate Deterioration of the Child‐Pugh Classification From A to B After Transcatheter Arterial Chemo‐Embolization for Treatment‐Naive Hepatocellular Carcinoma. Cancer Medicine. 2024. doi:10.1002/cam4.70367

BibTeX
@article{Asano2024,
  author = {Asano, Kazuo and Kageyama, Ken and Yamamoto, Akira and Jogo, Atsushi and Nakano, Mariko and Murai, Kazuki and Yukawa-Muto, Yoshimi and Odagiri, Naoshi and Kotani, Kohei and Kozuka, Ritsuzo and Kawamura, Etsushi and Fujii, Hideki and Uchida-Kobayashi, Sawako and Enomoto, Masaru and Kawada, Norifumi and Miki, Yukio},
  title = {Predictors of Immediate Deterioration of the Child‐Pugh Classification From A to B After Transcatheter Arterial Chemo‐Embolization for Treatment‐Naive Hepatocellular Carcinoma},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70367}
}
Kostenlos starten →